Advertisement
Screener

Unity Biotechnology, Inc. Patents: Active

Unity Biotechnology, Inc. Active Patents

17 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-08-07: Application 18215731; Invention Treatment of a Senescence-Associated Ocular Disease or Disorder Using a Bcl-xL Selective Inhibitor; Applicant Unity Biotechnology, Inc.; Status Patented Case.
  • 2022-04-12: Application 17719066; Invention Methods of Treating Retinal Vasculopathies; Applicant Unity Biotechnology, Inc.; Status Patented Case.
  • 2021-08-25: Application 17412003; Invention Methods of Inhibiting Pathological Angiogenesis; Applicant Unity Biotechnology, Inc.; Status Patented Case.
  • 2021-06-03: Application 17338368; Invention Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer; Applicant Unity Biotechnology, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-08-0718215731Treatment of a Senescence-Associated Ocular Disease or Disorder Using a Bcl-xL Selective InhibitorUnity Biotechnology, Inc.
Mayo Foundation for Medical Education and Research
Buck Institute for Research on Aging
Patented Case2025-04-2912285427US20240115563A1
Remi-Martin Laberge
Judith Campisi
Marco Demaria
Bennett G. Childs
Jan M. A. Van Deursen
Nathaniel David
Alain Philippe Vasserot
United States
United States
United States
United States
United States
United States
United States
HOWELL, THEODORE R
2022-04-1217719066Methods of Treating Retinal VasculopathiesUnity Biotechnology, Inc.Patented Case2024-04-0911951115US20220331345A1
Sharon Klier
Jamie Dananberg
United States
United States
SHIAO, REI TSANG
2021-08-2517412003Methods of Inhibiting Pathological AngiogenesisUnity Biotechnology, Inc.Patented Case2024-01-0911865123US20220072015A1
Pam Tsuruda
Jill Hopkins
Harry Sweigard
Yan Poon
Jamie Dananberg
Daniel Marquess
Nathaniel David
United States
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY
2021-06-0317338368Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating CancerUnity Biotechnology, Inc.Patented Case2025-02-1112221433US20220017485A1
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
JACKSON, SHAWQUIA
2020-11-1916953165ANTIBODIES DIRECTED TO TIE-2 AND METHODS OF USEUnity Biotechnology, Inc.Patented Case2025-01-1412195542US20210155697A1
Jason Damiano
Kristina Oresic Bender
Richard Theolis
Deepika Bhatnagar
Nina Ly
United States
United States
United States
United States
United States
ALLEN, MARIANNE P
2020-06-1016897905Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating CancerUnity Biotechnology, Inc.Patented Case2021-04-2010981892US20200317640A1
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
BERNHARDT, EMILY A
2020-02-1416791960Methods of Inhibiting Pathological AngiogenesisUnity Biotechnology, Inc.Patented Case2021-09-2811129838US20200253991A1
Pam Tsuruda
Jill Hopkins
Harry Sweigard
Yan Poon
Jamie Dananberg
Daniel Marquess
Nathaniel David
United States
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY
2019-09-2616584638TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM NEUROLOGICAL TISSUEUnity Biotechnology, Inc.
Mayo Foundation for Medical Education and Research
Buck Institute for Research on Aging
Patented Case2022-06-0711351167US20200030323A1
Remi-Martin Laberge
Judith Campisi
Marco Demaria
Nathaniel David
James L. Kirkland
Tamar Tchkonia
Yi Zhu
Darren J. Baker
Jan M.A. van Deursen
United States
United States
Netherlands
United States
United States
United States
United States
United States
United States
VIVLEMORE, TRACY ANN
2019-08-1216538557Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancerUNITY BIOTECHNOLOGY, INC.Patented Case2019-12-3110519197US20200002378A1
Ryan Hudson
Anne-Marie Beausoleil
F. Anthony Romero
Remi-Martin Laberge
United States
United States
United States
United States
LIEB, JEANETTE M
2019-06-1916446360Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating CancerUnity Biotechnology, Inc.Patented Case2020-07-2110717722US20190382371A1
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
BERNHARDT, EMILY A
2019-05-2916425665Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating CancerUnity Biotechnology, Inc.Patented Case2020-07-0710703745US20190367496A1
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
ANDERSON, REBECCA L
2019-05-2916425276Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating CancerUnity Biotechnology, Inc.Patented Case2020-08-1810745429US20190330250A1
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
BERNHARDT, EMILY A
2019-05-2916425228Phosphonamidates that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating CancerUnity Biotechnology, Inc.Patented Case2020-08-1110738042US20190330199A1
Anne-Marie Beausoleil
Ryan Hudson
United States
United States
BERNHARDT, EMILY A
2018-10-1516160840Technology to Inhibit Vascular Changes That Lead to Vision Loss in the EyeUnity Biotechnology, Inc.Patented Case2020-03-1710588916US20190151337A1
Pam Tsuruda
Jill Hopkins
Harry Sweigard
Yan Poon
Jamie Dananberg
Daniel Marquess
Nathaniel David
United States
United States
United States
United States
United States
United States
United States
PUTTLITZ, KARL J
2018-06-1516063135ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERSUnity Biotechnology, Inc.Patented Case2021-09-0711111259US20200291050A1
Bradley Backes
Thomas W. von Geldern
Bing Chen
United States
United States
China
RAMACHANDRAN, UMAMAHESWARI
2018-04-1815956613COMPOSITIONS OF MATTER FOR TREATMENT OF OPHTHALMIC CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM THE EYEUnity Biotechnology, Inc.
Mayo Foundation for Medical Education and Research
Buck Institute for Research on Aging
Patented Case2019-11-1910478432US20180235957A1
Remi-Martin Laberge
Judith Campisi
Marco Demaria
Nathaniel David
Alain Philippe Vasserot
James L. Kirkland
Tamar Tchkonia
Yi Zhu
Darren J. Baker
Bennett G. Childs
Jan M.A. van Deursen
United States
United States
Netherlands
United States
United States
United States
United States
United States
United States
United States
United States
HOWELL, THEODORE R
2017-11-3015827539TREATMENT OF OPHTHALMIC CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM THE EYEUnity Biotechnology, Inc.
Mayo Foundation for Medical Education and Research
Buck Institute for Research on Aging
Patented Case2018-07-0310010546US20180117038A1
Remi-Martin Laberge
Judith Campisi
Marco Demaria
Nathaniel David
Alain Philippe Vasserot
James L. Kirkland
Tamar Tchkonia
Yi Zhu
Darren J. Baker
Bennett G. Childs
Jan M.A. van Deursen
United States
United States
Netherlands
United States
United States
United States
United States
United States
United States
United States
United States
HOWELL, THEODORE R